Quantitative assessment of glomerular filtration rate with MR gadolinium slope clearance measurements: A phase I trial

Radiology

Volumn 242, Issue 3, 2007, Pages 783-790

  Boss, Andreas ^a   Martirosian, Petros ^a   Gehrmann, Michael ^a   Artunc, Ferruh ^a   Risler, Teut ^a   Oesingmann, Niels ^b   Claussen, Claus D ^a   Schick, Fritz ^a   Küper, Klaus ^a   Schlemmer, Heinz Peter ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b Siemens Medical Solutions ^*  (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CONTRAST MEDIUM; GADOBUTROL; IOPROMIDE; NUCLEAR MAGNETIC RESONANCE IMAGING AGENT;

ADULT; ARTICLE; BOLUS INJECTION; CLINICAL TRIAL; CONTRAST ENHANCEMENT; DRUG CLEARANCE; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; IMAGING SYSTEM; KIDNEY CORTEX; KIDNEY FUNCTION; LIVER; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; NORMAL HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PHANTOM; PHASE 1 CLINICAL TRIAL; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SPLEEN;

ADULT; CONTRAST MEDIA; FEASIBILITY STUDIES; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; KIDNEY; MAGNETIC RESONANCE IMAGING; MALE; ORGANOMETALLIC COMPOUNDS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 33847213864     PISSN: 00338419     EISSN: None     Source Type: Journal    
DOI: 10.1148/radiol.2423060209     Document Type: Article

References (24)

1. Choyke PL, Frank JA, Girton ME, et al. Dynamic Gd-DTPA-enhanced MR imaging of the kidney: experimental results. Radiology 1989;170:713-720.
2. Kikinis R, von Schulthess GK, Jager P, et al. Normal and hydronephrotic kidney: evaluation of renal function with contrast-enhanced MR imaging. Radiology 1987;165:837-842.
3. Knesplova L, Krestin GP. Magnetic resonance in the assessment of renal function. Eur Radiol 1998;8:201-211.
4. Fukuda Y, Watanabe H, Tomita T, Katayama H, Miyano T, Yabuta K. Evaluation of glomerular function in individual kidneys using dynamic magnetic resonance imaging. Pediatr Radiol 1996;26:324-328.
5. Laissy JP, Faraggi M, Lebtahi R, et al. Functional evaluation of normal and ischemic kidney by means of gadolinium-DOTA enhanced TurboFLASH MR imaging: a preliminary comparison with 99Tc-MAG3 dynamic scintigraphy. Magn Reson Imaging 1994;12:413-419.
6. Pettigrew RI, Avruch L, Dannels W, Coumans J, Bernardino ME. Fast-field-echa MR imaging with Gd-DTPA: physiologic evaluation of the kidney and liver. Radiology 1986;160:561-563.
7. Semelka RC, Hricak H, Tomei E, Floth A, Stoller M. Obstructive nephropathy: evaluation with dynamic Gd-DTPA-enhanced MR imaging. Radiology 1990;175:797-803.
8. Rohrschneider WK, Haufe S, Wiesel M, et al. Functional and morphologic evaluation of congenital urinary tract dilatation by using combined static-dynamic MR urography: findings in kidneys with a single collecting system. Radiology 2002;224:683-694.
9. Teh HS, Ang ES, Wong WC, et al. MR renography using a dynamic gradient-echo sequence and low-dose godopentelate dimeglumine as an alternative to radionuclide renography. AJR Am J Roentgenol 2003;181:441-450.
10. Schuhmann-Giampieri G, Krestin G. Pharmacokinetics of Gd-DTPA in patients with chronic renal failure. Invest Radiol 1991;26:975-979.
11. Krahe T, Gotz R, Lackner K, et al. Pharmacokinetics of gadolinium-DTPA in chronic renal insufficiency requiring dialysis [in German]. Rofo 1992;156:523-526.
12. Staks T, Schuhmann-Giampiere G, Frenzel T, Weinmann HJ, Lange L, Platzek J. Pharmacokinetics, dose proportionality, and tolerability of gadobutrol after single intravenous injection in healthy volunteers. Invest Radiol 1994;29:709-715.
13. Haustein J, Niendorf HP, Krestin G, et al. Renal tolerance of gadolinium-DTPA/dimeglumine in patients with chronic renal failure. Invest Radiol 1992;27:153-156.
14. Tombach R, Bremer C, Reimer P, et al. Renal tolerance of a neutral gadolinium chelate (gadobutrol) in patients with chronic venal failure: results of a randomized study. Radiology 2001;218:651-657.
15. Lee VS, Rusinek H, Noz ME, Lee P, Raghavan M, Kramer EL. Dynamic three-dimensional MR renography for the measurement of single kidney function: initial experience. Radiology 2003;227:289-294.
16. Rusinek H, Lee VS, Johnson G. Optimal dose of Gd-DTPA in dynamic MR studies. Magn Reson Med 2001;46:312-316.
17. Gates GF. Glomerular filtration rate: estimation from fractional accumulation of Tc-99m DTPA (stannous). AJR Am J Roentgenol 1982;138:565-570.
18. Hackstein N, Wiegand C, Rau WS, Langheinrich AC. Glomerular filtration rate measured by using triphasic helical CT with a two-point Patlak plot technique. Radiology 2004;230:221-226,
19. Hackstein N, Kooijman H, Tomaselli S, Rau WS. Glomerular filtration rate measured using the Patlak plot technique and contrast-enhanced dynamic MRI with different amounts of gadolinium-DTPA. J Magn Reson Imaging 2005;22:406-414.
20. Brown SG. Clinical features and severity grading of anaphylaxis. J Allergy Clin Immunol 2004;114:371-376.
21. Peters AM. The kinetic basis of glomerular filtration rate measurement and new concepts of indexation to body size. Eur J Nucl Med Mol Imaging 2004;31:137-149.
22. Haacke EM, Brown RW, Thompson MR, Venkatesan R. Magnetic resonance imaging: physical principles and sequence design. New York, NY: Wiley-Liss, 1999; 752.
23. Gaspari F, Perico N, Ruggenenti P, et al. Plasma clearance of nonradioactive iohexol as a measure of glomerular filtration rate. J Am Soc Nephrol 1995;6:257-263.
24. de Bazelaire CM, Duhamel GD, Rofsky NM, Alsop DC. MR imaging relaxation times of abdominal and pelvic tissues measured in vivo at 3.0 T; preliminary results. Radiology 2004;230:652-659.